These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 806894)

  • 1. [Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].
    Ménard J; Corvol P; Alexandre JM; Meignan M; N'Guyen-Phanh-Tam
    Nouv Presse Med; 1975 Jan; 4(1):17-20. PubMed ID: 806894
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
    Stumpe KO; Kolloch R; Gramann W; Vetter H; Krück F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1325-8. PubMed ID: 1029991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
    Khristov V; Maleeva A; Turkolev N
    Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic regulation of the heart in hypertension under intravenous administration of dihydralazine].
    Teichmann G; Dührkop G; Bellin H; Jung D; Börner H; Rostock G
    Z Gesamte Inn Med; 1974 Dec; 29(24):1030-2. PubMed ID: 4376311
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the humoral systems in juvenile arterial hypertension and their correction by using nifedipine and anaprilin].
    Bihar PV
    Lik Sprava; 1992 Aug; (8):67-9. PubMed ID: 1475932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Oct; 2(38):2539-46. PubMed ID: 4148700
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
    Laragh JH
    Am J Med; 1973 Sep; 55(3):261-74. PubMed ID: 4355699
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 19. [Essential hypertension: biochemical analysis--selective treatment].
    Bühler R; Laragh JH
    Schweiz Rundsch Med Prax; 1973 Apr; 62(16):489-91. PubMed ID: 4349069
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.